Patent Foramen Ovale Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
GORE ® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Conditions: Stroke; PFO - Patent Foramen Ovale Intervention: Device: PFO closure with GORE® CARDIOFORM Septal Occluder Sponsor: W.L.Gore & Associates Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2019 Category: Research Source Type: clinical trials